|1.||Zhu, Hong-Hu: 2 articles (12/2015 - 11/2013)|
|2.||Jiang, Hao: 2 articles (12/2015 - 11/2013)|
|3.||Huang, Xiao-Jun: 2 articles (12/2015 - 11/2013)|
|4.||Chen, Sai-Juan: 2 articles (11/2013 - 03/2008)|
|5.||Liang, Gong-Wen: 1 article (12/2015)|
|6.||Han, Sheng: 1 article (12/2015)|
|7.||Jiang, Qian: 1 article (12/2015)|
|8.||Shi, Lu-Wen: 1 article (12/2015)|
|9.||Xiao-Peng, He: 1 article (01/2014)|
|10.||Hao, Li: 1 article (01/2014)|
|1.||Acute Promyelocytic Leukemia
03/25/2008 - "In trying to address the possible beneficial effects of formulae with current biomedical approaches, we use Realgar-Indigo naturalis formula (RIF), which has been proven to be very effective in treating human acute promyelocytic leukemia (APL) as a model. "
01/01/2014 - "Clinical study on prospective efficacy of all-trans Acid, realgar-indigo naturalis formula combined with chemotherapy as maintenance treatment of acute promyelocytic leukemia."
01/01/2014 - "To test the efficiency and safety of sequential application of retinoic acid (ATRA), Realgar-Indigo naturalis formula (RIF) and chemotherapy (CT) were used as the maintenance treatment in patients with acute promyelocytic leukemia (APL). "
11/20/2013 - "This randomized, multicenter, phase III noninferiority trial was designed to test the efficacy and safety of an oral tetra-arsenic tetra-sulfide (As4S4) -containing formula named the Realgar-Indigo naturalis formula (RIF) compared with intravenous arsenic trioxide (ATO) as both induction and maintenance therapies for newly diagnosed acute promyelocytic leukemia (APL). "
12/01/2015 - "We have demonstrated that oral arsenic (Realgar-Indigo naturalis formula, RIF) plus all-trans retinoic acid (ATRA) is not inferior to intravenous arsenic trioxide (ATO) plus ATRA as the first-line treatment of acute promyelocytic leukemia (APL). "
|3.||Hematologic Diseases (Blood Diseases)
08/01/2010 - "No matter what ingredients of arsenic drugs were applied, either arsenic trioxide, arsenic disulfide, or arsenic containing Chinese herbal compositions including Qinghuang Powder and Realgar-Indigo naturalis formula, they all provided the distinct approaches for the management of malignant hematologic diseases, and good clinical efficacy was obtained with mild adverse reactions. "
|2.||arsenic trioxide (Trisenox)
|3.||Tretinoin (Retinoic Acid)
|4.||arsenic disulfide (realgar)
|1.||Drug Therapy (Chemotherapy)